Therefore, the search for ERBB2 mutations will become part of the standard management of breast and other cancers, as ERBB2 mutations are found across multiple cancers (e.g., uterine, cervical, colorectal, and lung) [16]. This evidence concerns the gene ERBB2 and cancer.